The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.


Updates from The Motley Fool

Latest updates on Biogen from Fool.com.  The Fool has written over 500 articles on Biogen.
3 Reasons to Sell Biogen

Image source: Pixabay. For biotech investors, Biogen (NASDAQ: BIIB) must have seemed like a por...

Better Buy: Amgen Inc. vs. Biogen

Image source: Getty Images. Blue-chip biotech stocks  Amgen (NASDAQ: AMGN) and  Biogen (NASDAQ:...

Rumors Swirl Around Biogen Today

Image source: Stockmonkeys.com via Flickr. Fresh on the heels of reporting success in a late-stag...



Stock Performance

View Interactive BIIB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Biogen.
Current Price: $285.30
Prev Close: $291.16
Open: $285.50
Bid: $282.00
Ask: $286.50
Day's Range: $280.50 - $288.97
52wk Range: $223.02 - $333.65
Volume: 1,967,195
Avg Vol 1,796,496
Market Cap: $64B
P/E (ttm): 19.78
EPS (ttm): $14.72
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Biogen.
CAPS Rating 5 out of 5
 
1011 Outperform
69 Underperform
CAPS All Stars
 
267 Outperform
11 Underperform

How do you think Biogen will perform against the market?



You pick for Biogen is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

George A. Scangos, CEO

81% Approve

Based on 266 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Biogen.

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers